Dr. Jeffrey R. Jay, M.D.

Great Point Partners as of March 31, 2018

Portfolio Holdings for Great Point Partners

Great Point Partners holds 32 positions in its portfolio as reported in the March 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Iovance Biotherapeutics (IOVA) 8.3 $56M 3.3M 16.90
Arena Pharmaceuticals 7.8 $52M 1.3M 39.50
Ptc Therapeutics I (PTCT) 7.0 $47M 1.7M 27.06
Kura Oncology (KURA) 6.6 $45M 2.4M 18.75
Zogenix 5.8 $39M 978k 40.05
Spark Therapeutics 5.4 $37M 550k 66.59
Global Blood Therapeutics In 5.3 $36M 742k 48.30
BioCryst Pharmaceuticals (BCRX) 5.3 $36M 7.5M 4.77
Puma Biotechnology (PBYI) 5.0 $34M 500k 68.05
Neurocrine Biosciences (NBIX) 4.9 $33M 400k 82.93
Rigel Pharmaceuticals (RIGL) 4.5 $30M 8.6M 3.54
Aimmune Therapeutics 4.3 $29M 901k 31.83
Foamix Pharmaceuticals 3.6 $25M 4.8M 5.13
Exelixis (EXEL) 3.0 $20M 900k 22.15
Prothena (PRTA) 2.7 $18M 500k 36.71
Acceleron Pharma 2.7 $18M 462k 39.10
Novocure Ltd ord (NVCR) 2.4 $16M 754k 21.80
Five Prime Therapeutics 2.2 $15M 868k 17.18
Achillion Pharmaceuticals 2.0 $14M 3.7M 3.71
Endocyte 2.0 $14M 1.5M 9.09
Corsicanto Ii Designated Act note 1.6 $11M 10M 1.10
Savara (SVRA) 1.2 $7.9M 862k 9.20
Cti Biopharma 1.0 $6.6M 1.7M 3.90
Amarin Corporation (AMRN) 1.0 $6.5M 2.2M 3.01
Catalyst Pharmaceutical Partners (CPRX) 1.0 $6.4M 2.7M 2.39
Sierra Oncology 1.0 $6.4M 3.1M 2.07
Vanda Pharmaceuticals (VNDA) 0.8 $5.2M 310k 16.85
Acorda Therapeutics 0.8 $5.2M 219k 23.65
Menlo Therapeutics 0.3 $2.0M 52k 37.57
Newlink Genetics Corporation 0.2 $1.7M 234k 7.25
Antares Pharma 0.2 $1.1M 500k 2.20
Streamline Health Solutions (STRM) 0.0 $239k 130k 1.84